PMC Links for Books (Select 4860592) - PMC

Select item 55744521.

Postauthorization safety study of the DPP-4 inhibitor saxagliptin: a large-scale multinational family of cohort studies of five outcomes

Vincent Lo Re, Dena M Carbonari, M Elle Saine, Craig W Newcomb, Jason A Roy, Qing Liu, Qufei Wu, Serena Cardillo, Kevin Haynes, Stephen E Kimmel, Peter P Reese, David J Margolis, Andrea J Apter, K Rajender Reddy, Sean Hennessy, Harshvinder Bhullar, Arlene M Gallagher, Daina B Esposito, Brian L Strom

BMJ Open Diabetes Res Care. 2017; 5(1): e000400. Published online 2017 Jul 31. doi: 10.1136/bmjdrc-2017-000400

PMCID:: PMC5574452

Abstract Article PDF–441K

Select item 45013392.

Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury

Masahiro Asakawa, Hiroshi Mitsui, Momoko Akihisa, Tetsuo Sekine, Yoshihiro Niitsu, Arisa Kobayashi, Atsuko Miyake, Naoaki Hashimoto, Mitsunobu Kawamura, Yoshihiro Ogawa

Springerplus. 2015; 4: 346. Published online 2015 Jul 15. doi: 10.1186/s40064-015-1135-z

PMCID:: PMC4501339

Abstract Article PDF–803K

Select item 44462353.

Features and Outcomes of 899 Patients with Drug-induced Liver Injury: The DILIN Prospective Study

N Chalasani, HL Bonkovsky, R Fontana, W Lee, A Stolz, J Talwalkar, KR Reddy, PB Watkins, V Navarro, H Barnhart, J Gu, J Serrano, for the United States Drug Induced Liver Injury Network

Gastroenterology. Author manuscript; available in PMC 2016 Jun 1.

Published in final edited form as: Gastroenterology. 2015 Jun; 148(7): 1340–1352.e7. Published online 2015 Mar 6. doi: 10.1053/j.gastro.2015.03.006

PMCID:: PMC4446235

Abstract Article PDF–546K

Select item 36542444.

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

Naga Chalasani, Robert J. Fontana, Herbert L. Bonkovsky, Paul B. Watkins, Timothy Davern, Jose Serrano, Hongqiu Yang, James Rochon, for the Drug Induced Liver Injury Network (DILIN)

Gastroenterology. Author manuscript; available in PMC 2013 May 15.

Published in final edited form as: Gastroenterology. 2008 Dec; 135(6): 1924–1934.e4. Published online 2008 Sep 17. doi: 10.1053/j.gastro.2008.09.011

PMCID:: PMC3654244

Abstract Article PDF–96K

Select item 35081135.

Efficacy and Safety of Taspoglutide Versus Sitagliptin for Type 2 Diabetes Mellitus (T-Emerge 4 Trial)

Richard M. Bergenstal, Adriana Forti, Jean-Louis Chiasson, Michael Woloschak, Mark Boldrin, Raffaella Balena

Diabetes Ther. 2012 Dec; 3(1): 13. Published online 2012 Nov 9. doi: 10.1007/s13300-012-0013-8

PMCID:: PMC3508113

Abstract Article PDF–1012K

Select item 31613956.

Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes

Debora Williams-Herman, Samuel S Engel, Elizabeth Round, Jeremy Johnson, Gregory T Golm, Hua Guo, Bret J Musser, Michael J Davies, Keith D Kaufman, Barry J Goldstein

BMC Endocr Disord. 2010; 10: 7. Published online 2010 Apr 22. doi: 10.1186/1472-6823-10-7

PMCID:: PMC3161395

Abstract Article PDF–1018K

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to:

Links from Books

Items: 6

Display Settings:

Send to:

Supplemental Content

Find related data

Recent activity